Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SAR leading to new topoisomerase I inhibitor presented by Banyu

Dec. 29, 1997

Peptidomimetic protein farnesyltransferase inhibitors in development at Merck

Dec. 24, 1997

ICI-182780 associated with longer remission duration than megestrol in resistant breast cancer

Dec. 22, 1997

Peptidomimetic inhibitors of protein farnesyltransferase from Merck & Co.

Dec. 22, 1997

Squalamine enters phase I for the treatment of cancer

Dec. 22, 1997

FDA Advisory Committee does not recommend approval for DepoCyt

Dec. 19, 1997

Farnesyltransferase inhibitors lacking a thiol moiety from Merck & Co.

Dec. 19, 1997

More on protein farnesyltransferase inhibitors from Merck & Co.

Dec. 18, 1997

Chemoprotective properties of lisofylline reported

Dec. 18, 1997

Indomethacin: antitumor activity and effects on telomerase

Dec. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 25, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 24, 2025
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...